Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
5
83%

Phase Distribution

5

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (83.3%)
Phase 31 (16.7%)

Trials by Status

not_yet_recruiting233%
terminated117%
unknown350%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_3

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT07753369
terminatedphase_1

A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)

NCT06245941
not_yet_recruitingphase_1

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

NCT06211751
unknownphase_1

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

NCT06165822
unknownphase_1

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

NCT05775575
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07753369Phase 3

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Not Yet Recruiting
NCT06245941Phase 1

A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)

Terminated
NCT06211751Phase 1

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

Not Yet Recruiting
NCT06165822Phase 1

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Unknown
NCT05775575Phase 1

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Unknown
NCT04975204Phase 1

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6